• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Osteoradionecrosis of the jaw in a patient with lymphoma treated with rituximab and concomitant involved field radiation therapy.

作者信息

Gonzalez-Lugo Jesus D, Kabarriti Rafi, Mantzaris Ioannis

机构信息

Department of Medicine, Albert Einstein College of Medicine, Jacobi Medical Center, Bronx, New York.

Department of Radiation Oncology, Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, New York.

出版信息

Adv Radiat Oncol. 2018 Jun 4;3(4):701-704. doi: 10.1016/j.adro.2018.05.008. eCollection 2018 Oct-Dec.

DOI:10.1016/j.adro.2018.05.008
PMID:30370372
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6200873/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b93a/6200873/2cc63dec3a98/adro207-fig-0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b93a/6200873/2cc63dec3a98/adro207-fig-0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b93a/6200873/2cc63dec3a98/adro207-fig-0001.jpg

相似文献

1
Osteoradionecrosis of the jaw in a patient with lymphoma treated with rituximab and concomitant involved field radiation therapy.一名接受利妥昔单抗及同期受累野放射治疗的淋巴瘤患者发生颌骨放射性骨坏死。
Adv Radiat Oncol. 2018 Jun 4;3(4):701-704. doi: 10.1016/j.adro.2018.05.008. eCollection 2018 Oct-Dec.
2
Osteoradionecrosis of the jaw.
Oral Surg Oral Med Oral Pathol. 1950 May;3(5):582-90. doi: 10.1016/0030-4220(50)90283-0.
3
Does intensity-modulated radiation therapy lower the risk of osteoradionecrosis of the jaw? A long-term comparative analysis.调强放疗是否降低颌骨放射性骨坏死的风险？一项长期的对比分析。
Int J Oral Maxillofac Surg. 2019 Nov;48(11):1387-1393. doi: 10.1016/j.ijom.2019.04.018. Epub 2019 Jun 20.
4
Influence of bisphosphonates on clinical features of osteoradionecrosis of the maxilla and mandible.双膦酸盐对颌骨放射性骨坏死临床特征的影响。
Oral Dis. 2019 Jul;25(5):1344-1351. doi: 10.1111/odi.13081. Epub 2019 Mar 26.
5
OSTEORADIONECROSIS OF THE JAW.
Odontol Tidskr. 1965 Apr 15;73:239-49.
6
Cause and occurrence timing of osteoradionecrosis of the jaw: a retrospective study focusing on prophylactic tooth extraction.颌骨放射性骨坏死的病因及发生时间：一项聚焦于预防性拔牙的回顾性研究
Oral Maxillofac Surg. 2016 Dec;20(4):337-342. doi: 10.1007/s10006-016-0570-5. Epub 2016 Jul 11.
7
Does radiation-induced fibrosis have an important role in pathophysiology of the osteoradionecrosis of jaw?放射性纤维化在颌骨放射性骨坏死的病理生理学中起重要作用吗？
Med Hypotheses. 2011 Jul;77(1):63-5. doi: 10.1016/j.mehy.2011.03.024. Epub 2011 Apr 2.
8
The prevalence and risk factors associated with osteoradionecrosis of the jaw in oral and oropharyngeal cancer patients treated with intensity-modulated radiation therapy (IMRT): The Memorial Sloan Kettering Cancer Center experience.接受调强放射治疗（IMRT）的口腔和口咽癌患者颌骨放射性骨坏死的患病率及相关危险因素：纪念斯隆凯特琳癌症中心的经验
Oral Oncol. 2017 Jan;64:44-51. doi: 10.1016/j.oraloncology.2016.11.015. Epub 2016 Dec 3.
9
Osteoradionecrosis of the jaws.
Pract Dent Monogr. 1958 Nov;26:1-51.
10
Teriparatide therapy for severe, refractory osteoradionecrosis of the jaw.特立帕肽治疗严重、难治性颌骨放射性骨坏死。
Osteoporos Int. 2018 Apr;29(4):987-992. doi: 10.1007/s00198-017-4343-2. Epub 2017 Dec 16.

本文引用的文献

1
Radiotherapy plus rituximab as first-line regimen for localized follicular lymphoma.放射治疗联合利妥昔单抗作为局限性滤泡性淋巴瘤的一线治疗方案。
Leuk Lymphoma. 2018 Jun;59(6):1420-1426. doi: 10.1080/10428194.2017.1387909. Epub 2017 Oct 10.
2
Osteonecrosis of the Jaw in a Patient Presenting With Post-Transplantation Lymphoproliferative Disorder Treated With Rituximab: A Case Report.利妥昔单抗治疗移植后淋巴细胞增生性疾病患者发生颌骨骨坏死：一例报告
J Oral Maxillofac Surg. 2017 Dec;75(12):2599-2605. doi: 10.1016/j.joms.2017.05.016. Epub 2017 May 24.
3
Osteoradionecrosis of the mandible in patients with oropharyngeal carcinoma treated with intensity-modulated radiotherapy.
调强放疗治疗口咽癌患者的下颌骨放射性骨坏死。
Cancer. 2017 Oct 1;123(19):3691-3700. doi: 10.1002/cncr.30803. Epub 2017 Jun 13.
4
The prevalence and risk factors associated with osteoradionecrosis of the jaw in oral and oropharyngeal cancer patients treated with intensity-modulated radiation therapy (IMRT): The Memorial Sloan Kettering Cancer Center experience.接受调强放射治疗（IMRT）的口腔和口咽癌患者颌骨放射性骨坏死的患病率及相关危险因素：纪念斯隆凯特琳癌症中心的经验
Oral Oncol. 2017 Jan;64:44-51. doi: 10.1016/j.oraloncology.2016.11.015. Epub 2016 Dec 3.
5
Newly diagnosed and relapsed follicular lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.新诊断及复发滤泡性淋巴瘤：ESMO诊断、治疗及随访临床实践指南
Ann Oncol. 2016 Sep;27(suppl 5):v83-v90. doi: 10.1093/annonc/mdw400.
6
Potential risk factors for jaw osteoradionecrosis after radiotherapy for head and neck cancer.头颈部癌放疗后颌骨放射性骨坏死的潜在风险因素。
Radiat Oncol. 2016 Jul 30;11:101. doi: 10.1186/s13014-016-0679-6.
7
Addition of Rituximab to Involved-Field Radiation Therapy Prolongs Progression-free Survival in Stage I-II Follicular Lymphoma: Results of a Multicenter Study.利妥昔单抗联合受累野放射治疗可延长Ⅰ-Ⅱ期滤泡性淋巴瘤患者的无进展生存期：一项多中心研究结果
Int J Radiat Oncol Biol Phys. 2016 Mar 15;94(4):783-91. doi: 10.1016/j.ijrobp.2015.12.019. Epub 2015 Dec 17.
8
Risk profile for osteoradionecrosis of the mandible in the IMRT era.调强放疗时代下颌骨放射性骨坏死的风险概况。
Strahlenther Onkol. 2016 Jan;192(1):32-9. doi: 10.1007/s00066-015-0875-6. Epub 2015 Aug 12.
9
Non-Hodgkin's lymphomas, version 2.2014.非霍奇金淋巴瘤，2014 年第 2 版。
J Natl Compr Canc Netw. 2014 Jun;12(6):916-46. doi: 10.6004/jnccn.2014.0086.
10
4 Gy versus 24 Gy radiotherapy for patients with indolent lymphoma (FORT): a randomised phase 3 non-inferiority trial.4 Gy 与 24 Gy 放疗治疗惰性淋巴瘤患者（FORT）：一项随机 3 期非劣效性试验。
Lancet Oncol. 2014 Apr;15(4):457-63. doi: 10.1016/S1470-2045(14)70036-1. Epub 2014 Feb 24.